NCT06203249
- Conditions
- Anti-MDA5 Antibody Positive Dermatomyositis, Immune Function, Microbiome
- Locations
-
- PLA Beijing, Beijing Municipality, China
Clinical trial condition
Anti-MDA5 Antibody Positive Dermatomyositis
Explore clinical trials studying Anti-MDA5 Antibody Positive Dermatomyositis. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study